Rahyza I F Assis

Dr. Rahyza I F Assis

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RARahyza I F Assis
Rahyza I F Assis
MWMalgorzata Wiench
Malgorzata Wiench
KSKarina G Silvério
Karina G Silvério
Rodrigo Augusto Foganholi da SilvaRodrigo Augusto Foganholi da Silva
Rodrigo Augusto Foganholi da Silva
GFGeórgia Feltran
Geórgia Feltran
DADenise C Andia
Denise C Andia
Human bone marrow-derived mesenchymal stem cells (hBMSCs) are important for tissue regeneration but their epigenetic regulation is not well understood. Here we investigate the ability of a non-nucleoside DNA methylation inhibitor, RG108 to induce epigenetic changes at both global and gene-specific levels in order to enhance mesenchymal cell markers, in hBMSCs. hBMSCs were treated with complete culture medium, 50 μM RG108 and DMSO for three days and subjected to viability and apoptosis assays, global and gene-specific methylation/hydroxymethylation, transcript levels’ analysis of epigenetic machinery enzymes and multipotency markers, protein activities of DNMTs and TETs, immunofluorescence staining and western blot analysis for NANOG and OCT4 and flow cytometry for CD105. The RG108, when used at 50 μM, did not affect the viability, apoptosis and proliferation rates of hBMSCs or hydroxymethylation global levels while leading to 75% decrease in DNMTs activity and 42% loss of global DNA methylation levels. In addition, DNMT1 was significantly downregulated while TET1 was upregulated, potentially contributing to the substantial loss of methylation observed. Most importantly, the mesenchymal cell markers CD105, NANOG and OCT4 were upregulated being NANOG and OCT4 epigenetically modulated by RG108, at their gene promoters. We propose that RG108 could be used for epigenetic modulation, promoting epigenetic activation of NANOG and OCT4, without affecting the viability of hBMSCs. DMSO can be considered a modulator of epigenetic machinery enzymes, although with milder effect compared to RG108.

5 February 2022 in Differentiation
Verified
Journal Article
Closed access
CSCatharina Marques Sacramento
Catharina Marques Sacramento
RARahyza I F Assis
Rahyza I F Assis
MSMiki Taketomi Saito
Miki Taketomi Saito
RCRicardo Della Coletta
Ricardo Della Coletta
MDMauricio Dourado
Mauricio Dourado
KRKarina Gonzales Silvério Ruiz
Karina Gonzales Silvério Ruiz

1 February 2021 in Developmental Biology
Verified
Journal Article
Closed access
RARahyza I F Assis
Rahyza I F Assis
GFGeórgia da S. Feltran
Geórgia da S. Feltran
MSMaria Eduarda Salomão Silva
Maria Eduarda Salomão Silva
IPIasmin Caroline Do Rosário Palma
Iasmin Caroline Do Rosário Palma
EREmanuel Silva Rovai
Emanuel Silva Rovai
Rodrigo Augusto Foganholi da SilvaRodrigo Augusto Foganholi da Silva
Rodrigo Augusto Foganholi da Silva

22 July 2021 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
RFRogério S. Ferreira
Rogério S. Ferreira
RARahyza I F Assis
Rahyza I F Assis
GFGeórgia Feltran
Geórgia Feltran
IPIasmin Caroline Do Rosário Palma
Iasmin Caroline Do Rosário Palma
BFBeatriz G. Françoso
Beatriz G. Françoso
Rodrigo Augusto Foganholi da SilvaRodrigo Augusto Foganholi da Silva
Rodrigo Augusto Foganholi da Silva

18 August 2023 in Genes
Verified
Journal Article
Open access
PDF file
RFRogério S. Ferreira
Rogério S. Ferreira
RARahyza I F Assis
Rahyza I F Assis
FRFrancesca Racca
Francesca Racca
ABAna Carolina Bontempi
Ana Carolina Bontempi
Rodrigo Augusto Foganholi da SilvaRodrigo Augusto Foganholi da Silva
Rodrigo Augusto Foganholi da Silva
DADenise C Andia
Denise C Andia
Chromatin conformation, DNA methylation pattern, transcriptional profile, and non-coding RNAs (ncRNAs) interactions constitute an epigenetic pattern that influences the cellular phenotypic commitment and impacts the clinical outcomes in regenerative therapies. Here, we investigated the epigenetic landscape of the SP7 transcriptor factor (SP7) and Distal-Less Homeobox 4 (DLX4) osteoblastic transcription factors (TFs), in human periodontal ligament mesenchymal cells (PDLCs) with low (l-PDLCs) and high (h-PDLCs) osteogenic potential. Chromatin accessibility (ATAC-seq), genome DNA methylation (Methylome), and RNA sequencing (RNA-seq) assays were performed in l- and h-PDLCs, cultured at 10 days in non-induced (DMEM) and osteogenic (OM) medium in vitro. Data were processed in HOMER, Genome Studio, and edgeR programs, and metadata was analyzed by online bioinformatics tools and in R and Python environments. ATAC-seq analyses showed the TFs genomic regions are more accessible in l-PDLCs than in h-PDLCs. In Methylome analyses, the TFs presented similar average methylation intensities (AMIs), without differently methylated probes (DMPs) between l- and h-PDLCs; in addition, there were no differences in the expression profiles of TFs signaling pathways. Interestingly, we identified the long non-coding RNAs (lncRNAs), MIR31HG and LINC00939, as upregulated in l-PDLCs, in both DMEM and OM. In the following analysis, the web-based prediction tool LncRRIsearch predicted RNA:RNA base-pairing interactions between SP7, DLX4, MIR31HG, and LINC00939 transcripts. The machine learning program TriplexFPP predicted DNA:RNA triplex-forming potential for the SP7 DNA site and for one of the LINC00939 transcripts (ENST00000502479). PCR data confirmed the upregulation of MIR31HG and LINC00939 transcripts in l-PDLCs (× h-PDLCs) in both DMEM and OM (p < 0.05); conversely, SP7 and DLX4 were downregulated, confirming those results observed in the RNA-Seq analysis. Together, these results indicate the lncRNAs MIR31HG and LINC00939 as possible epigenetic inhibitors of the osteogenic differentiation in PDLCs by (post)transcriptional and translational repression of the SP7 and DLX4 TFs.

1 March 2014 in Saúde e Sociedade
Verified
Journal Article
Open access
PDF file
MJManoelito Ferreira Silva Junior
Manoelito Ferreira Silva Junior
RARahyza I F Assis
Rahyza I F Assis
HSHedilberto Araújo de Sousa
Hedilberto Araújo de Sousa
PMPaula Vitali Miclos
Paula Vitali Miclos
MGMaria José Gomes
Maria José Gomes
A iniciação científica é uma oportunidade aos acadêmicos de desenvolver senso crítico, ético e profissional, com o intuito de aumentar a evidenciação científica e conduzir o que de melhor a prática odontológica pode oferecer. A universidade é um cenário importante de estímulo e incentivo à pesquisa, tendo um papel fundamental no desenvolvimento desta atividade, sendo necessário o apoio institucional e de professores interessados. O objetivo é conhecer o interesse dos graduandos do curso de Odontologia da Universidade Federal do Espírito Santo em relação à pesquisa científica. O estudo se caracteriza como descritivo transversal com abordagem quanti/qualitativa. A coleta de dados foi realizada com 101 acadêmicos do curso de Odontologia da Universidade Federal do Espírito Santo (UFES) através de um questionário semiestruturado, pré-validado, contendo perguntas sobre o interesse em pesquisa, participação em jornadas científicas e sobre o Trabalho de Conclusão de Curso (TCC). Os resultados encontrados foram: 79,2% relatam gostar de pesquisa científica e 81,19% têm interesse em pesquisar. É principalmente no 3o e 4o períodos que os alunos começam a frequentar eventos científicos, e na sua maioria, no 5o e 6o períodos começam a elaborar e apresentar trabalhos científicos. Conclui-se que um número considerável de acadêmicos de Odontologia mostra interesse e participa de pesquisas científicas, mesmo que a falta de incentivo financeiro, apoio dos professores e da infraestrutura não colabore para a realização de estudos com maior evidência científica.